BioCryst Pharmaceuticals
BCRX
#4649
Rank
C$3.21 B
Marketcap
C$12.65
Share price
0.34%
Change (1 day)
-7.39%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of March 2026 : C$0.65 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are C$0.65 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$0.70 B0.05%
2024-12-31C$0.70 B2.64%
2023-12-31C$0.68 B-8.13%
2022-12-31C$0.74 B-0.43%
2021-12-31C$0.74 B75.63%
2020-12-31C$0.42 B86.43%
2019-12-31C$0.22 B14.45%
2018-12-31C$0.20 B-10.75%
2017-12-31C$0.22 B85.62%
2016-12-31C$0.12 B-28.87%
2015-12-31C$0.16 B6.86%
2014-12-31C$0.15 B205.36%
2013-12-31C$52.01 M-8.93%
2012-12-31C$57.11 M-31.7%
2011-12-31C$83.62 M-23.57%
2010-12-31C$0.10 B-26.88%
2009-12-31C$0.14 B45.29%
2008-12-31C$0.10 B-27.67%
2007-12-31C$0.14 B78.55%
2006-12-31C$79.73 M-30.99%
2005-12-31C$0.11 B196.3%
2004-12-31C$38.99 M-0.11%
2003-12-31C$39.03 M-40.15%
2002-12-31C$65.22 M-30.71%
2001-12-31C$94.14 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
C$79.51 B 12,001.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$117.63 B 17,803.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$4.49 B 583.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$4.14 B 530.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.47 B 124.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$0.72 B 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$11.8 M-98.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$39.78 M-93.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$2.06 B 214.16%๐Ÿ‡บ๐Ÿ‡ธ USA